Innovix Pharma Inc. Report issue

For profit Phase 3
Founded: Calabasas CA United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2012
NCT01614249
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

fish oil (Omegavan) (1 trial)

soybean oil (Intralipid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2